Has Jocelyn Fitzgerald, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,958 in general payments to Jocelyn Fitzgerald, MD across 51 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jocelyn Fitzgerald, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jocelyn Fitzgerald, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jocelyn Fitzgerald, MD

Urogynecology and Reconstructive Pelvic Surgery · Pittsburgh, PANPI 1326482696

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Coloplast at 47.0% of the total. Reporting peaked in 2021 at $1,198 and has fallen 60.7% since, to $470 in 2025.

$3,958in general payments, 2019–2025

Across 51 payments — averaging $77.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Coloplast$2K
Axonics, Inc.$861
Boston Scientific$665
Medtronic$162
Renovia Inc$144
Caldera Medical, Inc$105
plus $160 from 3 others

$233,581in research payments, 2019–2025

Across 66 payments — averaging $3539.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Johnson & Johnson$234K

What the payments were for

Food & beverage$3,82697%
Education$1323%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Coloplast	20	$1,860
Axonics, Inc.	15	$861
Boston Scientific	10	$665
Medtronic	1	$162
Renovia Inc	1	$144
Caldera Medical, Inc	1	$105
Abbott	1	$98
Axsome Therapeutics, Inc.	1	$35
Applied Medical Resources Corporation	1	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,958 in reported general payments places this provider in the 60th percentile of 51 urogynecology and reconstructive pelvic surgery providers in Pennsylvania.

See all urogynecology and reconstructive pelvic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$32,791

Medicare patients

116

Services billed

240

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	220	$161,407
Mirabegron ErMirabegron	74	$38,949
Estradiol	299	$19,178
GemtesaVibegron	23	$15,812
Methenamine Hippurate	150	$8,230
PremarinEstrogens, Conjugated	16	$6,605
Trospium Chloride	55	$3,117
Trospium Chloride ErTrospium Chloride	19	$2,529
Clobetasol Propionate	45	$514
ValacyclovirValacyclovir Hcl	11	$441
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	40	$316
NitrofurantoinNitrofurantoin Macrocrystal	14	$284
Amitriptyline Hcl	15	$169

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Pittsburgh

Pamela MoalliPittsburgh$10K
Allan KlapperPittsburgh$10K
Lia MiceliPittsburgh$5K
Radhika PatnamPittsburgh$1K
Lauren GiugalePittsburgh$865
Amanda ArtsenPittsburgh$459
Ashley MurilloPittsburgh$308
Halina ZyczynskiPittsburgh$190
Mary AckenbomPittsburgh$132
Lindsay TurnerPittsburgh$97

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →